Valeant reports better-than-expected profit, raises forecast

(Reuters) - Canada's Valeant Pharmaceuticals International Inc , embroiled in a bitter fight to take over Botox maker Allergan Inc , posted a better-than-expected quarterly profit, driven by demand for its skin, neuro and eye drugs.

Source: Reuters: Health - October 20, 2014 Category: Consumer Health News Tags: healthNews Source Type: news